Biosign Signs Master Distribution Agreement With DLF Solutions Inc. for...
Toronto, April 16, 2010 (ots/PRNewswire) – Biosign Technologies Inc. (CNSX: BIO) (“Biosign” or the “Company”), and DLF Solutions Inc. (DLF), today announced they have signed a binding Heads of...
View ArticleBiosign Signs European Distribution Agreement
Toronto, July 2, 2010 (ots/PRNewswire) – Biosign Technologies Inc. (CNSX: BIO) today announced the signing of an exclusive Master Distribution Agreement with Swiss-based DynamiCARE AG to distribute the...
View ArticleColt wird an der OTCQX gelistet
Montreal (ots/PRNewswire) – Börsenkürzel: GTP – (CNSX) P01 – (FRANKFURT) COLTF.PK – (USA Pink Sheets) Colt Resources Inc. (“Colt” oder das “Unternehmen”) freut sich, bekanntgeben zu können, dass Colt...
View ArticleColt Resources Inc. schlägt Verlängerung und Abänderung von Optionsscheinen vor
Montreal (ots/PRNewswire) – Börsenkürzel: GTP – (CNSX) P01 – (FRANKFURT) COLTF.PK – (USA OTC Pink Sheets) Colt Resources Inc. (“Colt” oder das “Unternehmen”) schlägt vor, 3.908.000 Optionsscheine, die...
View ArticleColt ernennt neuen Direktor: Declan Costelloe
Montreal (ots/PRNewswire) – Handelskennzeichen: GTP – (CNSX) P01 – (FRANKFURT) COLTF.PK (US OTC Pink Sheets) Colt Resources Inc. (“Colt” oder das “Unternehmen”) ist erfreut darüber bekannt geben zu...
View ArticleColt fährt mit einer Privatplatzierung fort
Montreal (ots/PRNewswire) – Kennzeichen: GTP – (CNSX) P01 – (FRANKFURT) COLTF – (OTCQX) Colt Resources Inc. (“Colt” oder das “Unternehmen”) fährt mit einer nicht durch einen Broker vermittelten...
View ArticlePivotal Announces Scientific Presentation at the 17th World Congress on Heart...
Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CNSX:PVO), a specialty pharmaceutical company with a focus on cardiovascular health, is pleased to announce that data...
View ArticlePivotal Therapeutics Exhibiting at European Society of Cardiology Congress 2012
Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to...
View ArticlePivotal Therapeutics Inc. Generates Positive Feedback at European Society of...
Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to...
View ArticlePivotal’s Founder and Chairman Dr. George Jackowski receives Queen Elizabeth...
Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and...
View ArticlePivotal Therapeutics VASCAZEN®-REVEAL Trial Meets Primary and Secondary...
Woodbridge, Ontario (ots/PRNewswire) – Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and...
View ArticleHybrid Paytech Chooses Vodafone to Securely Connect its Pioneering Global...
Montreal (ots/PRNewswire) – World’s first service to securely process both debit and credit card transactions anywhere using standard mobile devices connected to card readers Hybrid PayTech, a division...
View Article
More Pages to Explore .....